Universal DX | About Us
UDX is an innovative biomedicine company focused on early detection of cancer
About Us, Universal Diagnostics, UDX, biomedicine, company, Diagnostics, Universal DX, cancer,
page-template,page-template-full_width,page-template-full_width-php,page,page-id-15587,ajax_fade,page_not_loaded,,wpb-js-composer js-comp-ver-6.2.0,vc_responsive

About Us

UDX is an in-vitro diagnostics biotech company focused on early detection of cancer using leading edge technologies.

Our vision

To make cancer a curable disease

by detecting it early. UDX is developing a Cancer Platform: a set of minimally-invasive, blood-based solutions for detecting cancer early when treatment-options are more plentiful.

See Why UDX

Our first product

CRC Screening Assay

UDX is developing a simple, minimally invasive, accurate and affordable blood-based screening assay to detect colorectal cancer and adenoma, allowing early detection and cancer prevention.

See Solution.



UDX has raised +20M€ investment from top international private investors, who strongly support our vision.

Results and Awards


UDX has presented results in various congresses.

UDX holds the award to the “Most Disruptive Healthcare Start-up” at 2015 Singularity Unversity Exponential Medicine Conference.



UDX has established an international network of alliances and collaborations with leading technological and medical institutions. UDX works with +60 hospitals, +200 biobanks and +10 of the best-in class technological centres, research institutions and universities worldwide.

See Alliances.



UDX headquarters are located in Sevilla, Spain. UDX performs R&D and other operations around Europe (Austria, UK, Slovenia, Belgium, and Madrid) and the US.

UDX has an international team of  scientists, researchers, clinical managers and tech entrepreneurs

inspired by its mission to positively impact humanity.


Founder and CEO of the first high-tech venture accelerator in Southern Europe. Launched +100 high-tech start-ups. MBA from MIT (USA), BS in Industrial Engineering from University of Seville (Spain). Graduated in Exponential Technologies at NASA-Singularity University (USA).


Founder and CEO

Founder and CEO of the genetic analysis company GenePlanet. Winner of MIT international genetics competition (iGem). BS and Master in Biotechnology. Graduated in Exponential Technologies at NASA-Singularity University (USA).


Founder and CINO

+10 years of experience in Life Science. Member of BCG’s leadership team in Operations. MBA from INSEAD and Executive Program on Emerging Technologies at NASA-Singularity University (USA).



Co-founder and Chairman of Bio-Oils, renewable energy. Co-founder and CEO of Jazztel telecom, listed in Nasdaq and Madrid. CEO of Optimus and Airtel (2nd & 3rd mobile operators in Portugal and Spain respectively). BS in Civil Engineering, Polytechnic University of Madrid. MBA from INSEAD.


Executive Director

Utilizamos cookies propias y de terceros para mejorar tu experiencia.
Si sigues navegando, consideramos que aceptas nuestra política de cookies. Más información.

Aviso de cookies